Thioredoxin mitigates H(2)O(2)‐induced inhibition of myogenic differentiation of rat bone marrow mesenchymal stem cells by enhancing AKT activation

Thioredoxin (Trx) is a hydrogen acceptor of ribonucleotide reductase and a regulator of some enzymes and receptors. It has been previously shown that significantly elevated levels of Trx expression are associated with the osteogenic differentiation of bone marrow mesenchymal stem cells (BMSCs), but...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Meiling, Li, Xianglu, Zhou, Changlin, Wang, Manfeng, Wang, Hongzhi, Ding, Haifeng, Cheng, Luyang, Gan, Lu, Wu, Xiaowei, Du, Zhimin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193161/
https://www.ncbi.nlm.nih.gov/pubmed/32160414
http://dx.doi.org/10.1002/2211-5463.12835

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7193161/
https://www.ncbi.nlm.nih.gov/pubmed/32160414
http://dx.doi.org/10.1002/2211-5463.12835

Ejemplares similares